Eurofarma

Semaglutide regulatory approvals and pricing in Brazil

4 clusters · 79 sources · last updated 3 days ago

Latest: Anvisa approves second generic semaglutide in Brazil

Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject

Brazil pharmaceutical supply and production strategy

3 clusters · 8 sources · last updated 8 days ago

Latest: Brazil targets 70% domestic pharmaceutical production by 2033

In late July 2026, Brazil reported severe drug shortages at high‑cost medication centers, with patients experiencing long waits and missing essential treatments for conditions such as cancer and epilepsy. At the Cemac Ju

Chikungunya outbreak and vaccine developments in MS

5 clusters · 44 sources · last updated 8 days ago

Latest: Mato Grosso do Sul reports 10,041 confirmed chikungunya cases

By the 32nd epidemiological week, Mato Grosso do Sul has seen a continued rise in chikungunya infections, reaching 10,041 confirmed cases out of 12,663 probable cases. The death toll remains at 30 confirmed fatalities, w